Meagan Carpenter
Internal Medicine · Waynesboro, MSNPI 1538553607
Payments from drug & device makers
Across 267 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$956
- Lilly USA, LLC$257
- Bayer$229
- Supernus Pharmaceuticals, Inc.$225
- Dexcom, Inc.$209
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,002100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 94 | $1,088 |
| AbbVie(2 entities) | 65 | $956 |
| Lilly USA, LLC | 17 | $257 |
| Bayer | 10 | $229 |
| Supernus Pharmaceuticals, Inc. | 8 | $225 |
| Dexcom, Inc. | 13 | $209 |
| AstraZeneca | 11 | $180 |
| Axsome Therapeutics, Inc. | 6 | $128 |
| Paratek Pharmaceuticals, Inc. | 4 | $73 |
| Pfizer | 4 | $65 |
| Corium, LLC | 2 | $53 |
| Amgen | 3 | $48 |
| Johnson & Johnson | 3 | $47 |
| Exact Sciences | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| Merck | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Biogen | 1 | $25 |
| Novartis | 1 | $23 |
| Insulet Corporation | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Corcept Therapeutics | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Galt Pharmaceuticals, LLC | 1 | $6 |
How this compares
$4,016 in reported general payments places this provider in the 85th percentile of 846 internal medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 86 | $88,528 |
| FarxigaDapagliflozin Propanediol | 81 | $75,856 |
| MounjaroTirzepatide | 51 | $59,809 |
| LinzessLinaclotide | 51 | $41,638 |
| EliquisApixaban | 46 | $33,580 |
| TrulicityDulaglutide | 16 | $22,963 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $22,361 |
| KerendiaFinerenone | 19 | $22,147 |
| JardianceEmpagliflozin | 24 | $22,106 |
| XareltoRivaroxaban | 11 | $14,955 |
| UbrelvyUbrogepant | 13 | $13,107 |
| MovantikNaloxegol Oxalate | 23 | $12,958 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $12,426 |
| MyrbetriqMirabegron | 22 | $9,861 |
| Xigduo XrDapaglifloz Propaned/Metformin | 16 | $9,131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,088 | $88,52886 claims |
| Lilly USA, LLCMounjaro, Trulicity | $257 | $82,77367 claims |
| AstraZenecaFarxiga | $180 | $75,85681 claims |
| AbbVieLinzess, Ubrelvy | $956 | $54,74664 claims |
| PfizerEliquis | $65 | $33,58046 claims |
| BayerKerendia | $229 | $22,14719 claims |
| Boehringer IngelheimJardiance | $19 | $22,10624 claims |
| Johnson & JohnsonXarelto | $47 | $14,95511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Waynesboro
- James HallBrookhaven$4.8M
- Bob HutchinsJackson$4.6M
- Sidney GortonBelzoni$571K
- David PendleyGulfport$336K
- Sarah KerutJackson$319K
- Gabriel HernandezJackson$196K
- Kelly WilkinsonJackson$183K
- Magdy Gorgi-MikhailBiloxi$157K
- Christina BarlowJackson$129K
- Arnold JacksonHattiesburg$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.